Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma

Although inhaled corticosteroid (ICS) use is associated with a decreased risk of hospitalization for asthma, the impact of ICS on the risk of life-threatening asthma exacerbation is less clear. The effect of ICS and inhaled beta agonist (IBA) dispensing on the risk of intensive care unit admission f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European respiratory journal 2001-02, Vol.17 (2), p.233-240
Hauptverfasser:	Eisner, M.D, Lieu, T.A, Chi, F, Capra, A.M, Mendoza, G.R, Selby, J.V, Blanc, P.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Administration, Oral Adrenergic beta-Agonists - administration & dosage Adrenergic beta-Agonists - adverse effects Adult Albuterol - administration & dosage Albuterol - analogs & derivatives Asthma - drug therapy Asthma - physiopathology Biological and medical sciences Cohort Studies Female Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Hospitalization Humans Intensive Care Units Logistic Models Male Medical sciences Middle Aged Patient Admission Pharmacology. Drug treatments Respiratory system Retrospective Studies Risk Factors Salmeterol Xinafoate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!